{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:35:25Z","timestamp":1781249725881,"version":"3.54.1"},"reference-count":45,"publisher":"Wiley","issue":"S2","license":[{"start":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T00:00:00Z","timestamp":1488758400000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Visible actinic keratosis (<jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content>) lesions and subclinical (non\u2010visible) sun damage in the field of cancerization are associated with risk of both non\u2010melanoma skin cancer, including basal cell carcinoma (<jats:styled-content style=\"fixed-case\">BCC<\/jats:styled-content>) and squamous cell carcinoma (<jats:styled-content style=\"fixed-case\">SCC<\/jats:styled-content>), and, more rarely, melanoma. As the incidences of <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> and skin cancer are increasing, effective prevention and treatment of <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> is essential to minimize disease burden and improve patient quality of life. Currently, <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> lesions are often left untreated and field therapies are underused. Patient\u2010centred care, with a focus on the patient\u2010physician relationship, has proven cost\u2010effective, and improved clinical outcomes and patient satisfaction in a number of therapy areas. Strategies for applying patient\u2010centred care to <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> are warranted. Existing barriers to the effective treatment of <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> were identified and patient\u2010centric strategies to overcome each barrier were discussed. Barriers to effective <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> treatment include poor disease awareness (for both patient and physician), concerns associated with the cosmetic effects of treatment, treatment\u2010related side effects, cost perceptions for lesion\u2010directed vs field\u2010directed therapies, and inadequate adherence, particularly with long treatment duration. Overcoming these barriers will involve patient and physician education that promotes: disease prevention and awareness; the importance of self\u2010examination; an understanding of treatment options; and the importance of adherence to treatment. To maximize its effectiveness, education should be delivered within a patient\u2010centric framework, where the relationship between patient and physician is built on effective communication, empathy and a feeling of partnership. Patient\u2010centric care, including patient education, is key to overcoming the barriers associated with effective <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> treatment.<\/jats:p>","DOI":"10.1111\/jdv.14091","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T11:50:31Z","timestamp":1488801031000},"page":"17-20","source":"Crossref","is-referenced-by-count":19,"title":["The importance of patient\u2010centred care to overcome barriers in the management of actinic keratosis"],"prefix":"10.1111","volume":"31","author":[{"given":"R.","family":"Cerio","sequence":"first","affiliation":[{"name":"Department of Cutaneous Medicine &amp; Surgery The Royal London Hospital &amp; QMUL Bart's Health NHS Trust Whitechapel London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,3,6]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13180"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12833"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1159\/000254893"},{"key":"e_1_2_4_5_1","first-page":"S2","article-title":"Comprehensive management of actinic keratoses: practical integration of available therapies with a review of a newer treatment approach","volume":"7","author":"Rosso JQ","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2013.05.028"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24284"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12420"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25691"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-015-0295-4"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-015-0070-9"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.11.037"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12016"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.01.036"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.6.722"},{"key":"e_1_2_4_16_1","first-page":"796","article-title":"The impact of patient\u2010centered care on outcomes","volume":"49","author":"Stewart M","year":"2000","journal-title":"J Fam Pract"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2011.03.100170"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2004.00993.x"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.031237"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1159\/000245677"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02056.x"},{"key":"e_1_2_4_22_1","unstructured":"British Academy of Dermatologists.Cryotherapy PIL.2014. URLhttp:\/\/www.bad.org.uk\/for-the-public\/patient-information-leaflets\/cryotherapy\/?showmore=1&returnlink=http%3A%2F%2Fwww.bad.org.uk%2Ffor-the-public%2Fpatient-information-leaflets#.Vp-i7lJln-k(last accessed 01 June 2016)."},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/1011-1344(92)85108-7"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb02630.x"},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12434"},{"key":"e_1_2_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.09.051"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000366530"},{"key":"e_1_2_4_28_1","unstructured":"European Medicines Agency.Zyclara 3.75% cream EU summary of product characteristics.2015. URL:http:\/\/www.medicines.org.uk\/EMC\/medicine\/27323\/SPC\/Zyclara+3.75++cream\/(last accessed 01 June 2016)."},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.2174\/187221312798889301"},{"key":"e_1_2_4_30_1","unstructured":"European Medicines Agency.5\u2010fluorouracil summary of product characteristics.2015. URL:http:\/\/www.medicines.org.uk\/emc\/medicine\/6219\/SPC\/Efudix+Cream(last accessed 01 June 2016)."},{"key":"e_1_2_4_31_1","unstructured":"European Medicines Agency.Diclofenac summary of product characteristics.2016. URL:https:\/\/www.medicines.org.uk\/emc\/medicine\/24377(last accessed 01 June 2016)."},{"key":"e_1_2_4_32_1","unstructured":"ShroffN.Practical implementation tips: actinic keratosis.2015. URL:www.guidelinesinpractice.co.uk\/apr_15_shroff_actinickeratosis#.Vfs_4vSld-4(last accessed 01 June 2016)."},{"key":"e_1_2_4_33_1","first-page":"35","article-title":"Non\u2010adherence to topical treatments for actinic keratosis","volume":"8","author":"Shergill B","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"e_1_2_4_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1111170"},{"key":"e_1_2_4_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2008.562"},{"key":"e_1_2_4_36_1","first-page":"1","article-title":"Actinic keratosis: sequelae and treatments. Recommendations from a consensus panel","volume":"55","author":"Berman B","year":"2006","journal-title":"J Fam Pract"},{"key":"e_1_2_4_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12840"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-015-0211-7"},{"key":"e_1_2_4_39_1","unstructured":"National Institute for Health and Care Excellence.Skin cancer prevention. NICE public health guidance 32. January2011. URL:https:\/\/www.nice.org.uk\/guidance\/ph32\/resources\/skin-cancer-prevention-1996294114501(last accessed 01 June 2016)."},{"key":"e_1_2_4_40_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2003.tb05532.x"},{"key":"e_1_2_4_41_1","first-page":"CD001005","article-title":"Limited (information only) patient education programs for adults with asthma","volume":"2","author":"Gibson PG","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_4_42_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta11050"},{"key":"e_1_2_4_43_1","unstructured":"RickertJ.Patient\u2010Centered Care: What It Means And How To Get There.2012. URL:http:\/\/healthaffairs.org\/blog\/2012\/01\/24\/patient-centered-care-what-it-means-and-how-to-get-there\/(last accessed 01 June 2016)."},{"key":"e_1_2_4_44_1","doi-asserted-by":"publisher","DOI":"10.1370\/afm.285"},{"key":"e_1_2_4_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7318.908"},{"key":"e_1_2_4_46_1","doi-asserted-by":"publisher","DOI":"10.1177\/0163278704267037"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.14091","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.14091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T14:44:29Z","timestamp":1694529869000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.14091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":45,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.1111\/jdv.14091"],"URL":"https:\/\/doi.org\/10.1111\/jdv.14091","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}